Company Microbot Medical Inc.

Equities

MBOT

US59503A2042

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly revenue - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-13 pm EDT			5-day change	1st Jan Change
0.9276 ^USD	+0.47%		-4.37%	-43.44%

Apr. 29	Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	CI
Apr. 16	HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	MT

Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the bodyâs vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.

Number of employees: 22

Managers	Title	Age	Since
Harel Gadot CEO	Chief Executive Officer	52	88-08-01
Rachel Vaknin DFI	Director of Finance/CFO	45	21-12-31
Juan Diaz-Cartelle CTO	Chief Tech/Sci/R&D Officer	-	Nov. 30
Simon Sharon CTO	Chief Tech/Sci/R&D Officer	64	18-04-04

Members of the board	Title	Age	Since
Scott Burell BRD	Director/Board Member	59	16-11-27
Laxmin Laxminarain BRD	Director/Board Member	66	17-12-11
Tal Wenderow BRD	Director/Board Member	50	20-07-31
Harel Gadot CEO	Chief Executive Officer	52	88-08-01
Yossi Bornstein FOU	Founder	66	88-08-01
Martin Madden BRD	Director/Board Member	64	17-02-05
Aileen Stockburger BRD	Director/Board Member	62	20-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	14,398,964	14,156,936 ( 98.32 %)	0	98.32 %

Name	Equities	%	Valuation
Vanguard Global Advisers LLC 3.192 %	459,549	3.192 %	396 591 $
Armistice Capital LLC 2.083 %	300,000	2.083 %	258 900 $
Yossi Bornstein 1.681 %	242,028	1.681 %	208 870 $
BlackRock Institutional Trust Co. NA 0.9541 %	137,375	0.9541 %	118 555 $
Harel Gadot 0.9504 %	136,847	0.9504 %	118 099 $
Renaissance Technologies LLC 0.7361 %	105,995	0.7361 %	91 474 $
Contego Capital Group, Inc. 0.6945 %	100,000	0.6945 %	86 300 $
Alphacentric Advisors LLC 0.6945 %	100,000	0.6945 %	86 300 $
Geode Capital Management LLC 0.6417 %	92,404	0.6417 %	79 745 $
HRT Financial LLC 0.4024 %	57,941	0.4024 %	50 003 $

Microbot Medical, Inc.

288 Grove Street Suite 388

02184, Braintree

+781 875 3605

http://microbotmedical.com

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.9233 USD

Average target price

7 USD

Spread / Average Target

+658.16%

Consensus

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MICROBOT MEDICAL INC.	-42.99%	13.29M
MODERNA, INC.	+25.82%	44.96B
IQVIA HOLDINGS INC.	-0.83%	42.65B
LONZA GROUP AG	+46.00%	41.85B
CELLTRION, INC.	-5.31%	29.04B
ICON PUBLIC LIMITED COMPANY	+9.46%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.14%	19.03B
BIO-TECHNE CORPORATION	+6.03%	12.75B
MEDPACE HOLDINGS, INC.	+28.44%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.24%	11.75B

Other Biotechnology & Medical Research